PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 7.89
+0.12 (1.54%)
At close: Jan 22, 2026
PlexBio Market Cap
PlexBio has a market cap or net worth of 805.36 million as of January 22, 2026. Its market cap has decreased by -32.14% in one year.
Market Cap
805.36M
Enterprise Value
480.51M
Revenue
153.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.89
Market Cap Chart
Since February 26, 2016, PlexBio's market cap has decreased from 1.58B to 805.36M, a decrease of -49.00%. That is a compound annual growth rate of -6.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 805.36M | -0.13% |
| Dec 31, 2025 | 806.39M | -37.00% |
| Dec 31, 2024 | 1.28B | -12.41% |
| Dec 29, 2023 | 1.46B | 17.01% |
| Dec 30, 2022 | 1.25B | -32.68% |
| Dec 30, 2021 | 1.86B | -23.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |